Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive versus standard atorvastatin for borderline vulnerable coronary plaques in unstable angina
ChiCTR-ONRC-12002035Phase 4Completed
- Sponsor
- Shanghai Pudong New Area Gongli Hospital
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of atorvastatin in coronary arteriosclerosis and unstable angina (2 arms), sponsored by Shanghai Pudong New Area Gongli Hospital. Primary endpoints: Plaque volume, Vessel volume and 1 more. Started Aug 2008; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronary arteriosclerosisunstable angina
Beyond the preview
Go deeper on ChiCTR-ONRC-12002035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-12002035.